Your session is about to expire
← Back to Search
OCS Liver Transplant Recipients for Liver Transplant (OLP-II Trial)
N/A
Recruiting
Research Sponsored by TransMedics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
All liver transplant recipients who are transplanted with an OCS-perfused donor liver are eligible for the Registry
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-year
Awards & highlights
OLP-II Trial Summary
OLP-II Registry is a sponsor-initiated, multi-center, observational, post-approval registry.
OLP-II Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowOLP-II Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1-year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Survival
OLP-II Trial Design
1Treatment groups
Experimental Treatment
Group I: OCS Liver Transplant RecipientsExperimental Treatment1 Intervention
All liver transplant recipients who are transplanted with an OCS-perfused donor liver are eligible for the Registry. Up to 10,000 subjects will be enrolled.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
OCS Liver
2016
N/A
~330
Find a Location
Who is running the clinical trial?
TransMedicsLead Sponsor
22 Previous Clinical Trials
8,571 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger